Abbott Laboratories share price today
(NASDAQ: ABT)

Name: Abbott Laboratories Share Price Today (NASDAQ: ABT) - Abbott Laboratories Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Abbott Laboratories share price is $123.22 & ₹10,657.30 as on 24 Jan 2025, 2.30 'hrs' IST

$123.22

▲

5.44

(4.62%)

Market is closed - opens 8 PM, 24 Jan 2025

View live Abbott Laboratories share price in Dollar and Rupees. Guide to invest in Abbott Laboratories stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Abbott Laboratories, along with analyst recommendations, forecasts, and comprehensive financials.

Abbott Laboratories share price movements

Today's Low: $118.18
Today's High: $123.22
$123.22
4.09%
Downside
Day's Volatility :4.09%
Upside
0.0%
52 Weeks Low: $99.71
52 Weeks High: $123.22
$123.22
19.08%
Downside
52 Weeks Volatility :19.08%
Upside
0.0%

Abbott Laboratories Returns

Period	Abbott Laboratories	Sector (Health Care)	S&P500
3 Months	3.12%	-4.8%	4.8%
6 Months	11.92%	-5.1%	12.1%
1 Year	4.74%	2.5%	25.0%
3 Years	-4.45%	10.2%	38.0%

Abbott Laboratories Key Statistics

in dollars & INR

Previous Close	$117.78
Open	$118.13
Today's High	$123.22
Today's Low	$118.18
Market Capitalization	$202.6B
Today's Volume	$13.0M
52 Week High	$123.22
52 Week Low	$99.71
Revenue TTM	$41.2B
EBITDA	$10.8B
Earnings Per Share (EPS)	$3.39
PE Ratio	34.45
Dividend Yield	2.08%
Profit Margin	13.99%
Quarterly Earnings Growth YOY	0.15%
Return On Equity TTM	14.84%

How to invest in Abbott Laboratories Stock (ABT) from India?

It is very easy for Indian residents to invest directly in Abbott Laboratories from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Abbott Laboratories stock in both Indian Rupees (INR) and US Dollars (USD). Search for Abbott Laboratories or ABT on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Abbott Laboratories or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Abbott Laboratories shares which would translate to 0.007 fractional shares of Abbott Laboratories as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Abbott Laboratories, in just a few clicks!

Returns in Abbott Laboratories for Indian investors in Rupees

Investment Value

₹1,00,000

Abbott Laboratories investment value today

Current value as on today

₹1,13,687

Returns

₹13,687

(+13.69%)

Returns from Abbott Laboratories Stock

₹9,578 (+9.58%)

Dollar Returns

₹4,109 (+4.11%)

Indian investors sentiment towards Abbott Laboratories

-12.38%

Period: Oct 25, 2024 to Jan 23, 2025. Change in 30 Days versus previous period

Investment in Abbott Laboratories from India has reduced in the last 30 days as on Jan 24, 2025. -12.38% less purchase transactions for Abbott Laboratories in the last 30 days versus the previous period.

10%

Period: Oct 25, 2024 to Jan 23, 2025. Change in 30 Days versus previous period

Search volume for Abbott Laboratories on INDmoney from India has grown in the last 30 days as on Jan 24, 2025. 10% more investors are searching Abbott Laboratories in the last 30 days versus the previous period.

Indian Mutual Funds that invest in Abbott Laboratories

Name	Shares Held	Change in Shares	% of Assets
DSP Healthcare Fund Direct Growth	31600	513.50	0.92%
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth	2625	0.00	1.61%
Motilal Oswal S&P 500 Index Fund Direct Growth	14962	-95.76	0.39%

Global Institutional Holdings in Abbott Laboratories

Vanguard Group Inc
9.68%
BlackRock Inc
7.55%
State Street Corp
4.42%
Capital Research & Mgmt Co - Division 3
3.79%
Capital Research Global Investors
3.07%
Geode Capital Management, LLC
2.01%

Analyst Recommendation on Abbott Laboratories

Buy

75%Buy

24%Hold

0%Sell

Based on 29 Wall street analysts offering stock ratings for Abbott Laboratories(by analysts ranked 0 to 5 stars)

Based on 29 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Abbott Laboratories

What analysts predicted

Upside of 6.01%

Target:

$130.62

Current:

$123.22

Insights on Abbott Laboratories

Price Movement
In the last 7 days, ABT stock has moved up by 3.8%
Increasing Revenue
Abbott Laboratories has shown strong revenue growth over the last three quarters. The company's revenue increased from $9.96 billion to $10.63 billion, marking an average increase of 3.2% each quarter.
Increasing Net Profit
Abbott Laboratories has shown positive profit trends over the last three quarters. The net profit increased from $1.22 billion to $1.64 billion, which is an average increase of 13.4% per quarter.

Abbott Laboratories Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$30.6B	↑ 11.64%
Net Income	$2.4B	↑ 396.44%
Net Profit Margin	7.74%	↑ 6.0%

	FY19	Y/Y Change
Revenue	$31.9B	↑ 4.34%
Net Income	$3.7B	↑ 55.7%
Net Profit Margin	11.56%	↑ 3.82%

	FY20	Y/Y Change
Revenue	$34.6B	↑ 8.48%
Net Income	$4.5B	↑ 21.91%
Net Profit Margin	12.99%	↑ 1.43%

	FY21	Y/Y Change
Revenue	$43.1B	↑ 24.47%
Net Income	$7.1B	↑ 57.31%
Net Profit Margin	16.42%	↑ 3.43%

	FY22	Y/Y Change
Revenue	$43.7B	↑ 1.34%
Net Income	$6.9B	↓ 1.95%
Net Profit Margin	15.88%	↓ 0.54%

	FY23	Y/Y Change
Revenue	$40.1B	↓ 8.12%
Net Income	$5.7B	↓ 17.45%
Net Profit Margin	14.27%	↓ 1.61%

	Q2 FY23	Q/Q Change
Revenue	$10.0B	↑ 2.37%
Net Income	$1.4B	↑ 4.32%
Net Profit Margin	13.78%	↑ 0.26%

	Q3 FY23	Q/Q Change
Revenue	$10.1B	↑ 1.65%
Net Income	$1.4B	↑ 4.44%
Net Profit Margin	14.16%	↑ 0.38%

	Q4 FY23	Q/Q Change
Revenue	$10.2B	↑ 0.97%
Net Income	$1.6B	↑ 11.0%
Net Profit Margin	15.56%	↑ 1.4%

	Q1 FY24	Q/Q Change
Revenue	$10.0B	↓ 2.7%
Net Income	$1.2B	↓ 23.15%
Net Profit Margin	12.29%	↓ 3.27%

	Q2 FY24	Q/Q Change
Revenue	$10.4B	↑ 4.14%
Net Income	$1.3B	↑ 6.29%
Net Profit Margin	12.55%	↑ 0.26%

	Q3 FY24	Q/Q Change
Revenue	$10.6B	↑ 2.49%
Net Income	$1.6B	↑ 26.42%
Net Profit Margin	15.48%	↑ 2.93%

	FY18	Y/Y Change
Profit	$17.9B	↑ 18.73%

	FY19	Y/Y Change
Profit	$18.7B	↑ 4.48%

	FY20	Y/Y Change
Profit	$19.6B	↑ 4.99%

	FY21	Y/Y Change
Profit	$24.5B	↑ 25.16%

	FY22	Y/Y Change
Profit	$24.5B	↓ 0.11%

	FY23	Y/Y Change
Profit	$22.1B	↓ 9.7%

	Q2 FY23	Q/Q Change
Profit	$5.5B	↑ 1.14%

	Q3 FY23	Q/Q Change
Profit	$5.5B	↑ 0.78%

	Q4 FY23	Q/Q Change
Profit	$5.3B	↓ 5.06%

	Q1 FY24	Q/Q Change
Profit	$5.5B	↑ 5.44%

	Q2 FY24	Q/Q Change
Profit	$5.8B	↑ 4.74%

	Q3 FY24	Q/Q Change
Profit	$5.9B	↑ 2.24%

	FY18	Y/Y Change
Operating Cash Flow	$6.3B	↑ 13.11%
Investing Cash Flow	$-1.4B	↓ 85.9%
Financing Cash Flow	$-10.4B	↑ 96.76%

	FY19	Y/Y Change
Operating Cash Flow	$6.1B	↓ 2.6%
Investing Cash Flow	$-1.8B	↑ 33.85%
Financing Cash Flow	$-4.3B	↓ 58.72%

	FY20	Y/Y Change
Operating Cash Flow	$7.9B	↑ 28.76%
Investing Cash Flow	$-2.2B	↑ 22.04%
Financing Cash Flow	$-2.8B	↓ 35.21%

	FY21	Y/Y Change
Operating Cash Flow	$10.5B	↑ 33.31%
Investing Cash Flow	$-2.0B	↓ 9.35%
Financing Cash Flow	$-5.5B	↑ 97.7%

	FY22	Y/Y Change
Operating Cash Flow	$9.6B	↓ 9.04%
Investing Cash Flow	$-1.7B	↓ 13.35%
Financing Cash Flow	$-7.6B	↑ 38.99%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$1.2B	↑ 5.25%
Investing Cash Flow	$-1.2B	↑ 162.55%
Financing Cash Flow	$-1.3B	↓ 8.58%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$1.9B	↑ 56.03%
Investing Cash Flow	$-634.0M	↓ 47.73%
Financing Cash Flow	$-2.3B	↑ 81.54%

Abbott Laboratories Technicals Summary

Sell

Neutral

Buy

Abbott Laboratories is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Abbott Laboratories Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Abbott Laboratories	2.18%	11.92%	4.74%	-4.45%	31.47%
Johnson & Johnson	-0.21%	-9.57%	-8.96%	-13.34%	-2.34%
Pfizer Inc.	-2.07%	-15.47%	-5.31%	-50.49%	-35.23%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Abbott Laboratories	34.45	34.45	2.2	4.67	0.15	0.06	0.02	22.94
Johnson & Johnson	24.33	24.33	0.86	9.96	0.21	0.08	0.03	29.14
Pfizer Inc.	35.05	35.05	0.2	2.92	0.05	0.03	0.07	16.29

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Abbott Laboratories	Buy	$202.6B	31.47%	34.45	13.99%
Johnson & Johnson	Buy	$356.7B	-2.34%	24.33	16.74%
Pfizer Inc.	Hold	$151.0B	-35.23%	35.05	7.16%

Abbott Laboratories Dividend announcements

Abbott Laboratories Dividends March, 2025
In the quarter ending March,2025. Abbott Laboratories has declared dividend of $0.59
Read More

About Abbott Laboratories

Abbott Laboratories, headquartered in Chicago, Illinois, was founded in 1888 by a physician named Dr Wallace Calvin. His purpose was to improve people's well-being and help them reach their full potential at different stages of their lives. Founded as a drug formulation company, today, Abbott Laboratories is a worldwide leader in healthcare, medical devices, nutritional products, and pharmaceutical drugs. Even though it reached the shores of India a century ago, it is still regarded as one of the largest healthcare product companies. With a focus on cardiovascular, diagnostic, diabetes, and neuromodulation products, some of its popular brands include Pedialyte, Glucerna, Similac, Ensure, and iStat. Abbott opened its first international office in London in 1907, and currently operates in over 160 countries. Its growth is also a result of strategic acquisitions. Abbott’s recent acquisitions include Kalo Pharma International in 2014, which doubled its brand generic drug portfolio. It acquired Tendyne in 2015 and along with it the company’s minimally invasive mitral valve replacement therapies. Another gem in the crown is the acquisition of Alere in 2016, which gave Abbott access to the largest mail-order diabetic supplier, Arriva Medical. Along with strategic acquisitions, the company is dedicated to gaining a strong competitive advantage. With the onset of COVID-19, the company has developed various antibody tests that have been granted emergency-use authorization. According to Forbes, Abbott Laboratories' fast and low-cost testing methods have expedited the detection of COVID-19 virus. For its 2030 sustainability plan, the company is gearing up to introduce revolutionary products such as BinaxNOW, a COVID-19 test, and FreeStyle Libre, an innovative glucose monitoring device. Abbott’s future plans are centred around providing cutting-edge technologies at affordable prices to even the most vulnerable sections of society. Currently Abbott Laboratories has a market cap of $196.19 Billion. It has a P.E ratio of 35.31. The shares of Abbott Laboratories are trading at $117.78. .

Organization	Abbott Laboratories
Employees	114000
CEO	Mr. Robert B. Ford
Industry	Health Technology

Management People of Abbott Laboratories

Name	Title
Mr. Robert B. Ford	Chairman of the Board, President & CEO
Mr. Philip P. Boudreau	CFO & Executive VP of Finance
Mr. Hubert L. Allen J.D.	Executive VP, General Counsel & Secretary
Mr. Daniel Gesua Sive Salvadori	Executive VP and Group President of Established Pharmaceuticals & Nutritional Products
Ms. Lisa D. Earnhardt	Executive VP & Group President of Medical Devices
Ms. Sabina Ewing	Senior VP of Business & Technology Services and Chief Information Officer
Mr. Michael Comilla	Vice President of Investor Relations.
Erica L. Battaglia	VP and Chief Ethics & Compliance Officer
Ms. Mary K. Moreland	Executive Vice President of Human Resources
Ms. Melissa Brotz	Senior Vice President of Global Marketing & External Affairs

Important FAQs about investing in Abbott Laboratories (ABT) from India :

What is Abbott Laboratories share price today?

Abbott Laboratories share price today stands at $123.22, Open: $118.13 ; Previous Close: $117.78 ; High: $123.22 ; Low: $118.18 ; 52 Week High: $123.22 ; 52 Week Low: $99.71. The stock opens at $118.13, after a previous close of $117.78. The stock reached a daily high of $123.22 and a low of $118.18, with a 52-week high of $123.22 and a 52-week low of $99.71.

Can Indians buy Abbott Laboratories shares?

Yes, Indians can invest in the Abbott Laboratories (ABT) from India.

With INDmoney, you can buy Abbott Laboratories at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Abbott Laboratories at zero transaction cost.

How can I buy Abbott Laboratories shares from India?

It is very easy to buy Abbott Laboratories from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Abbott Laboratories be purchased?

Yes, you can buy fractional shares of Abbott Laboratories with INDmoney app.

What are the documents required to start investing in Abbott Laboratories stocks?

To start investing in Abbott Laboratories, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.